ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP Last Month

January 28, 2011

St. Jude Offers Three Fellowships

March 2, 1984

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

April 9, 2010

In Brief: NCI Figure Left unchanged By Carter; Pay Raise Puts further Squeeze On Institute Budget

March 4, 1977

Marijuana-Derived Drug Less Effective Than Standard

March 29, 2002

NCI To Hold Symposium To Honor Wener Kirsten

April 2, 1993